Bessemer Group’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28K Sell
1,086
-217
-17% -$5.03K ﹤0.01% 1884
2026
Q1
$27K Sell
1,303
-132
-9% -$2.98K ﹤0.01% 1844
2025
Q4
$34K Buy
1,435
+758
+112% +$18.5K ﹤0.01% 1740
2025
Q3
$17K Sell
677
-1,496
-69% -$32.2K ﹤0.01% 1762
2025
Q2
$50K Sell
2,173
-96
-4% -$2.22K ﹤0.01% 1336
2025
Q1
$51K Buy
2,269
+2,178
+2,393% +$50.6K ﹤0.01% 1312
2024
Q4
$2K Buy
+91
New +$1.8K ﹤0.01% 2257
2023
Q4
Sell
-104
Closed -$2K 2256
2023
Q3
$2K Buy
+104
New +$2.65K ﹤0.01% 2015
2023
Q1
Sell
-8,674
Closed -$197K 2032
2022
Q4
$197K Buy
+8,674
New +$241K ﹤0.01% 894

Other funds holding PRVA

Bessemer Group's PRVA Position: Q2 2026 in Review

Bessemer Group reduced its Privia Health (PRVA) stake by 17% in Q2 2026, selling an estimated $5.03K and leaving 1,086 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #1884.

Bessemer Group first reported a position in PRVA in Q4 2022 and has held it in 9 quarters since. The position peaked at $197K in Q4 2022. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Bessemer Group held 1,086 shares of Privia Health worth $28K as of Q2 2026.
  • Bessemer Group sold 217 Privia Health shares in Q2 2026, an estimated $5.03K.
  • Privia Health made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1884 holding.
  • Bessemer Group first reported a position in Privia Health in Q4 2022 and has held it in 9 quarters since.
  • Bessemer Group's Privia Health position peaked at $197K in Q4 2022.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.